Pregled bibliografske jedinice broj: 1207112
Imidazo[4,5-b]pyridine derived tubulin polymerization inhibitors: Design, synthesis, biological activity in vitro and computational analysis
Imidazo[4,5-b]pyridine derived tubulin polymerization inhibitors: Design, synthesis, biological activity in vitro and computational analysis // Bioorganic chemistry, 127 (2022), 106032, 13 doi:10.1016/j.bioorg.2022.106032 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1207112 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Imidazo[4,5-b]pyridine derived tubulin
polymerization inhibitors: Design, synthesis,
biological activity in vitro and computational
analysis
Autori
Boček, Ida ; Hok, Lucija ; Persoons, Leentje ; Daelemans, Dirk ; Vianello, Robert ; Hranjec, Marijana
Izvornik
Bioorganic chemistry (0045-2068) 127
(2022);
106032, 13
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
acrylonitriles ; amination ; antiproliferative activity in vitro ; imidazo[4, 5-b]pyridine ; docking simulations ; molecular dynamic simulations ; tubulin polymerization
Sažetak
Imidazo[4, 5-b]pyridine derived acrylonitriles were synthesized and explored for their in vitro antiproliferative effect on a diverse human cancer cell line panel. Three compounds, 20, 21 and 33, showed strong activity in the submicromolar range (IC50 0.2–0.6 μM), and were chosen for further biological experiments. Immunofluorescence staining and tubulin polymerization assays confirmed tubulin as the main target, but excluded its colchicine-binding site as a potential interacting unit. This was supported by the computational analysis, which revealed that the most potent ligands act on the extended colchicine site on the surface between interacting tubulin subunits, where they interfere with their polymerization and reveal pronounced antitumor properties. In addition, lead molecule 21 potently inhibited cancer cell migration, while it did not affect the viability of normal cells even at the highest concentration tested (100 μM).
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biologija, Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ-IP-2018-01-4379 - Istraživanje antioksidativnog djelovanja benzazolskog skeleta u dizajnu novih antitumorskih agensa (AntioxPot) (Hranjec, Marijana, HRZZ - 2018-01) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb
Profili:
Robert Vianello (autor)
Marijana Hranjec (autor)
Lucija Hok (autor)
Ida Boček Pavlinac (autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- CA Search (Chemical Abstracts)